Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis

Molecular Therapy

Volumn 23, Issue 6, 2015, Pages 1044-1054

  Kang, Shin Ae ^a   Hasan, Nafis ^b   Mann, Aman P ^c   Zheng, Wei ^a   Zhao, Lichao ^a   Morris, Lynsie ^a   Zhu, Weizhu ^a   Zhao, Yan D ^a   Suh, K Stephen ^d   Dooley, William C ^a   Volk, David ^c   Gorenstein, David G ^c   Cristofanilli, Massimo ^e   Rui, Hallgeir ^e   Tanaka, Takemi ^a  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; E SELECTIN TARGETED APTAMER; HERMES ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN A; APTAMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN METASTASIS; BREAST METASTASIS; CANCER CHEMOTHERAPY; CANCER PREVENTION; CELL ADHESION; CELL HOMING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS INHIBITION; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; SHEAR RESISTANT ADHESION; SINGLE DRUG DOSE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BREAST TUMOR; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; MCF-7 CELL LINE; METABOLISM; NEOPLASM METASTASIS; TUMOR CELL LINE;

MUS;

ANIMALS; APTAMERS, NUCLEOTIDE; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84930178523     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.45     Document Type: Article

References (47)

1. Coleman, RE and Rubens, RD (1987). The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66
2. Disibio, G and French, SW (2008). Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132: 931-939
3. Patanaphan, V, Salazar, OM and Risco, R (1988). Breast cancer: metastatic patterns and their prognosis. South Med J 81: 1109-1112
4. Swenerton, KD, Legha, SS, Smith, T, Hortobagyi, GN, Gehan, EA, Yap, HY et al. (1979). Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39: 1552-1562
5. Smid, M, Wang, Y, Zhang, Y, Sieuwerts, AM, Yu, J, Klijn, JG et al. (2008). Subtypes of breast cancer show preferential site of relapse. Cancer Res 68: 3108-3114
6. Solomayer, EF, Diel, IJ, Meyberg, GC, Gollan, C and Bastert, G (2000). Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59: 271-278
7. Weigelt, B, Peterse, JL and van 't Veer, LJ (2005). Breast cancer metastasis: markers and models. Nat Rev Cancer 5: 591-602
8. Chiang, AC and Massagú J (2008). Molecular basis of metastasis. N Engl J Med 359: 2814-2823
9. Pantel, K and Brakenhoff, RH (2004). Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456
10. Hiratsuka, S, Goel, S, Kamoun, WS, Maru, Y, Fukumura, D, Duda, DG et al. (2011). Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci USA 108: 3725-3730
11. Kaplan, RN, Riba, RD, Zacharoulis, S, Bramley, AH, Vincent, L, Costa, C et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827
12. Bevilacqua, MP (1993). Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11: 767-804
13. Woodward, J (2008). Crossing the endothelium: E-selectin regulates tumor cell migration under flow conditions. Cell Adh Migr 2: 151-152
14. Thankamony, SP and Sackstein, R (2011). Enforced hematopoietic cell E- and L-selectin ligand (HCELL) expression primes transendothelial migration of human mesenchymal stem cells. Proc Natl Acad Sci USA 108: 2258-2263
15. Thomas, W (2008). Catch bonds in adhesion. Annu Rev Biomed Eng 10: 39-57
16. Nguyen, DX, Bos, PD and Massagú J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284
17. Chambers, AF, Groom, AC and MacDonald, IC (2002). Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572
18. Tremblay, PL, Auger, FA and Huot, J (2006). Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25: 6563-6573
19. Zollner, TM and Asadullah, K (2003). Selectin and selectin ligand binding: a bittersweet attraction. J Clin Invest 112: 980-983
20. Sackstein, R (2011). The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives. Curr Opin Hematol 18: 239-248
21. Mann, AP, Somasunderam, A, Nieves-Alicea, R, Li, X, Hu, A, Sood, AK et al. (2010). Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting. PLoS One 5: e13050
22. Psaila, B and Lyden, D (2009). The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9: 285-293
23. Hiratsuka, S, Watanabe, A, Aburatani, H and Maru, Y (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369-1375
24. Jacobs, PP and Sackstein, R (2011). CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett 585: 3148-3158
25. Julien, S, Ivetic, A, Grigoriadis, A, QiZe, D, Burford, B, Sproviero, D et al. (2011). Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 71: 7683-7693
26. Friederichs, J, Zeller, Y, Hafezi-Moghadam, A, Gr?e, HJ, Ley, K and Altevogt, P (2000). The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60: 6714-6722
27. Louderbough, JM and Schroeder, JA (2011). Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 9: 1573-1586
28. Lopez, JI, Camenisch, TD, Stevens, MV, Sands, BJ, McDonald, J and Schroeder, JA (2005). CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 65: 6755-6763
29. Aktas, B, Tewes, M, Fehm, T, Hauch, S, Kimmig, R and Kasimir-Bauer, S (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11: R46
30. Theodoropoulos, PA, Polioudaki, H, Agelaki, S, Kallergi, G, Saridaki, Z, Mavroudis, D et al. (2010). Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288: 99-106
31. Baccelli, I, Schneeweiss, A, Riethdorf, S, Stenzinger, A, Schillert, A, Vogel, V et al. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol 31: 539-544
32. Shirure, VS, Reynolds, NM and Burdick, MM (2012). Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells. PLoS One 7: e44529
33. Zen, K, Liu, DQ, Guo, YL, Wang, C, Shan, J, Fang, M et al. (2008). CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS One 3: e1826
34. Geng, Y, Yeh, K, Takatani, T and King, MR (2012). Three to tango: MUC1 as a ligand for both E-selectin and ICAM-1 in the breast cancer metastatic cascade. Front Oncol 2: 76
35. Gout, S, Morin, C, Houle, F and Huot, J (2006). Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 66: 9117-9124
36. Dimitroff, CJ, Descheny, L, Trujillo, N, Kim, R, Nguyen, V, Huang, W et al. (2005). Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65: 5750-5760
37. Shirure, VS, Liu, T, Delgadillo, LF, Cuckler, CM, Tees, DF, Benencia, F et al. (2015). CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions. Am J Physiol Cell Physiol 308: C68-C78
38. Ponta, H, Sherman, L and Herrlich, PA (2003). CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45
39. Prochazka, L, Tesarik, R and Turanek, J (2014). Regulation of alternative splicing of CD44 in cancer. Cell Signal 26: 2234-2239
40. Bánky, B, RÁSÓBarnett, L, Barbai, T, TÁMÁR, J, Becságh, P and RÁSÓ E (2012)
41. Li, C, Kato, M, Shiue, L, Shively, JE, Ares, M Jr and Lin, RJ (2006). Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res 66: 1990-1999
42. Kim, MY, Oskarsson, T, Acharyya, S, Nguyen, DX, Zhang, XH, Norton, L et al. (2009). Tumor self-seeding by circulating cancer cells. Cell 139: 1315-1326
43. Cameron, MD, Schmidt, EE, Kerkvliet, N, Nadkarni, KV, Morris, VL, Groom, AC et al. (2000). Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60: 2541-2546
44. Mazo, IB and von Andrian, UH (1999). Adhesion and homing of blood-borne cells in bone marrow microvessels. J Leukoc Biol 66: 25-32
45. Decuzzi, P, Lee, S, Bhushan, B and Ferrari, M (2005). A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng 33: 179-190
46. Decuzzi, P, Lee, S, Decuzzi, M and Ferrari, M (2004). Adhesion of microfabricated particles on vascular endothelium: a parametric analysis. Ann Biomed Eng 32: 793-802
47. Minn, AJ, Gupta, GP, Siegel, PM, Bos, PD, Shu, W, Giri, DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524